In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

A decade ago, the NFL’s “Next Gen” journey started with hardware. The league embedded RFID chips into every player’s shoulder ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...

Unlike traditional testing, which requires hundreds or thousands of charge – discharge cycles, the model can estimate a new ...

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.

Since the dawn of the computer age, researchers have wrestled with two persistent challenges: how to store ever-increasing ...

It’s no longer about hiring specialists. The market now demands hybrid marketers: people who can speak to both business goals ...

The government is asking experts and academics to help shape a plan to tackle the growing issue of deepfakes, ITV News ...

AI-based procurement software is used by organisations for sourcing goods, managing suppliers, and managing overall spend.

Evolving toxicity assessments for engineered nanoparticles underline the importance of predictive models and life-cycle risk ...